These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 16545608)
1. Defective translation initiation causes vanishing of cerebral white matter. Scheper GC; Proud CG; van der Knaap MS Trends Mol Med; 2006 Apr; 12(4):159-66. PubMed ID: 16545608 [TBL] [Abstract][Full Text] [Related]
2. Regulation of protein synthesis in lymphoblasts from vanishing white matter patients. van Kollenburg B; Thomas AA; Vermeulen G; Bertrand GA; van Berkel CG; Pronk JC; Proud CG; van der Knaap MS; Scheper GC Neurobiol Dis; 2006 Mar; 21(3):496-504. PubMed ID: 16185887 [TBL] [Abstract][Full Text] [Related]
3. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Leegwater PA; Vermeulen G; Könst AA; Naidu S; Mulders J; Visser A; Kersbergen P; Mobach D; Fonds D; van Berkel CG; Lemmers RJ; Frants RR; Oudejans CB; Schutgens RB; Pronk JC; van der Knaap MS Nat Genet; 2001 Dec; 29(4):383-8. PubMed ID: 11704758 [TBL] [Abstract][Full Text] [Related]
4. Vanishing white matter disease. van der Knaap MS; Pronk JC; Scheper GC Lancet Neurol; 2006 May; 5(5):413-23. PubMed ID: 16632312 [TBL] [Abstract][Full Text] [Related]
5. [From gene to disease; a defect in the regulation of protein production leading to vanishing white matter]. Pronk JC; Leegwater PA; van der Knaap MS Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1933-6. PubMed ID: 12404908 [TBL] [Abstract][Full Text] [Related]
6. The spectrum of mutations for the diagnosis of vanishing white matter disease. Scali O; Di Perri C; Federico A Neurol Sci; 2006 Sep; 27(4):271-7. PubMed ID: 16998732 [TBL] [Abstract][Full Text] [Related]
7. The large spectrum of eIF2B-related diseases. Fogli A; Boespflug-Tanguy O Biochem Soc Trans; 2006 Feb; 34(Pt 1):22-9. PubMed ID: 16246171 [TBL] [Abstract][Full Text] [Related]
8. Leukoencephalopathy with vanishing white matter: a review. Bugiani M; Boor I; Powers JM; Scheper GC; van der Knaap MS J Neuropathol Exp Neurol; 2010 Oct; 69(10):987-96. PubMed ID: 20838246 [TBL] [Abstract][Full Text] [Related]
10. A mouse model for eukaryotic translation initiation factor 2B-leucodystrophy reveals abnormal development of brain white matter. Geva M; Cabilly Y; Assaf Y; Mindroul N; Marom L; Raini G; Pinchasi D; Elroy-Stein O Brain; 2010 Aug; 133(Pt 8):2448-61. PubMed ID: 20826436 [TBL] [Abstract][Full Text] [Related]
11. Vanishing white matter disease: a review with focus on its genetics. Pronk JC; van Kollenburg B; Scheper GC; van der Knaap MS Ment Retard Dev Disabil Res Rev; 2006; 12(2):123-8. PubMed ID: 16807905 [TBL] [Abstract][Full Text] [Related]
12. Leucoencephalopathy with vanishing white matter may cause progressive myoclonus epilepsy. Jansen AC; Andermann E; Niel F; Creveaux I; Boespflug-Tanguy O; Andermann F Epilepsia; 2008 May; 49(5):910-3. PubMed ID: 18266750 [TBL] [Abstract][Full Text] [Related]
13. [Eukaryotic translation initiation factor 2B and leukoencephalopathy with vanishing white matter]. Pan YX; Wu Y; Niu ZP; Jiang YW Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):608-10. PubMed ID: 19829687 [TBL] [Abstract][Full Text] [Related]
14. A case of ovarioleukodystrophy without eIF2B mutations. Gaudiano C; Di Perri C; Scali O; Rufa A; Battisti C; De Stefano N; Federico A J Neurol Sci; 2008 May; 268(1-2):183-6. PubMed ID: 18061208 [TBL] [Abstract][Full Text] [Related]
15. The unfolded protein response in vanishing white matter disease. van der Voorn JP; van Kollenburg B; Bertrand G; Van Haren K; Scheper GC; Powers JM; van der Knaap MS J Neuropathol Exp Neurol; 2005 Sep; 64(9):770-5. PubMed ID: 16141786 [TBL] [Abstract][Full Text] [Related]
16. Mutations linked to leukoencephalopathy with vanishing white matter impair the function of the eukaryotic initiation factor 2B complex in diverse ways. Li W; Wang X; Van Der Knaap MS; Proud CG Mol Cell Biol; 2004 Apr; 24(8):3295-306. PubMed ID: 15060152 [TBL] [Abstract][Full Text] [Related]
17. Poor cerebral inflammatory response in eIF2B knock-in mice: implications for the aetiology of vanishing white matter disease. Cabilly Y; Barbi M; Geva M; Marom L; Chetrit D; Ehrlich M; Elroy-Stein O PLoS One; 2012; 7(10):e46715. PubMed ID: 23056417 [TBL] [Abstract][Full Text] [Related]
18. Identification of ten novel mutations in patients with eIF2B-related disorders. Ohlenbusch A; Henneke M; Brockmann K; Goerg M; Hanefeld F; Kohlschütter A; Gärtner J Hum Mutat; 2005 Apr; 25(4):411. PubMed ID: 15776425 [TBL] [Abstract][Full Text] [Related]
19. Vanishing white matter: deregulated integrated stress response as therapy target. Abbink TEM; Wisse LE; Jaku E; Thiecke MJ; Voltolini-González D; Fritsen H; Bobeldijk S; Ter Braak TJ; Polder E; Postma NL; Bugiani M; Struijs EA; Verheijen M; Straat N; van der Sluis S; Thomas AAM; Molenaar D; van der Knaap MS Ann Clin Transl Neurol; 2019 Aug; 6(8):1407-1422. PubMed ID: 31402619 [TBL] [Abstract][Full Text] [Related]
20. A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation. Ghezzi L; Scarpini E; Rango M; Arighi A; Bassi MT; Tenderini E; De Riz M; Jacini F; Fumagalli GG; Pietroboni AM; Galimberti D; Bresolin N Neurology; 2012 Nov; 79(20):2077-8. PubMed ID: 23115207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]